Great Capabilities.
We may be new to the US, but we’ve been delivering safe and effective plasma-derived therapies to patients globally for more than 50 years.
GC Biopharma is committed to improving the lives of people around the world and has built a global network of professionals and facilities to make this a reality.
- GC Biopharma is a pioneer in the field of specialty pharmaceuticals, manufacturing its first plasma-derived therapy in South Korea in 1971
- Today, GC Biopharma is among the top pharmaceutical manufacturers of plasma therapeutics worldwide, distributing to more than 50 countries
- GC Biopharma has one of the largest plasma manufacturing facilities in the world.
- Headquartered in South Korea, GC Biopharma has offices in the US, Brazil, Vietnam, China, and South Korea
Global Reach
Throughout its history, which spans half a century, GC Biopharma has developed the field of specialty pharmaceuticals, with a focus on plasma-derived drug products. GC Biopharma is devoted to developing new drugs to achieve its mission and vision.
